Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Jan Skokowski"'
Autor:
Ewa Jassem, Rodryg Ramlau, Rafał Dziadziuszko, Amelia Szymanowska, Joanna Jakóbkiewicz, Katarzyna Lamperska, Grażyna Kobierska, Jan Skokowski, Wojciech Dyszkiewicz, Andrzej Mackiewicz, Maciej Żylicz, Jacek Jassem
Publikováno v:
Pneumonologia i Alergologia Polska. 7:64-70
Autor:
Dariusz Tomaszewski, Ina Zając-Lenczewska, Łukasz Plichta, Mariusz Łapiński, Maciej Murawski, Adam Sternau, Jan Skokowski
Publikováno v:
Pneumonologia i Alergologia Polska. 72:477-481
Autor:
Jacek Jassem, Eugenia Czestochowska, Klaus Hermann Wiedorn, Kazimierz Jaśkiewicz, Carsten Boltze, Dorota Dworakowska, Rafal Dworakowski, Ewa Jassem, Jan Skokowski
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 131:479-485
Purpose: The aim of this study was to assess the impact of cyclin D1 overexpression (considered separately or jointly with previously assessed p53 and pRb statuses) on survival in a group of 111 surgically treated non-small cell lung cancer patients
Autor:
Dorota Dworakowska, Jan Skokowski, Rafal Dworakowski, Kazimierz Jaśkiewicz, Carsten Boltze, Klaus Hermann Wiedorn, Jacek Jassem, Eugenia Czestochowska, Ewa Jassem
Publikováno v:
Acta Oncologica. 44:75-79
Prognostic value of p21WAF1/CIP1 expression in non-small-cell lung cancer patients (NSCLC) remains unclear. In this study the authors investigated the clinical significance of p21WAF1/CIP1 expression in a group of 117 NSCLC patients, who underwent cu
Publikováno v:
European Journal of Cardio-Thoracic Surgery. 25:509-514
Objective: Thoracic dumb-bell tumors are rare, usually benign tumors in the posterior mediastinum, consisting of intrathoracic and intraspinal parts. Surgical removal is the treatment of choice, performed by two teams – neurosurgeons and thoracic s
Autor:
Grażyna Kobierska-Gulida, Amelia Szymanowska, Albert Roessner, Jacek Jassem, Brigitte Peters, Maciej Żylicz, Dorota Dworakowska, Rafal Dziadziuszko, Ewa Jassem, Regine Schneider-Stock, Jan Skokowski, Joanna Jakóbkiewicz-Banecka
Publikováno v:
Lung Cancer. 43:285-295
The prognostic impact of MDM2 amplification in non-small cell lung cancer (NSCLC) remains unknown. In this study, we investigated the occurrence of MDM2 amplification in surgically treated NSCLC patients. Molecular data were correlated with clinicopa
Autor:
Jan Skokowski, Artur Raiter, Amelia Szymanowska, Rafal Dziadziuszko, Radoslaw Wilimski, Witold Rzyman, Jacek Jassem
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 126:755-760
Background It has been postulated that allogeneic transfusions have immunosuppressive effects that can promote tumor growth and metastasis formation. Despite the variety of publications on this controversial topic, the influence of blood transfusion
Autor:
G Kobierska, Ewa Jassem, Damps I, Jan Skokowski, Dorota Dworakowska, Jacek Jassem, A Urbaniak, Andrzej Badzio, Stanisław Góźdź
Publikováno v:
Lung Cancer. 35:35-41
Prognostic value of p53 and PCNA expression in non-small cell lung cancer (NSCLC) remains controversial. In this study we determined the relevance of these abnormalities in terms of overall survival and disease-free survival in 95 NSCLC patients who
Autor:
Wieslawa Niklinska, G Kobierska, Lech Chyczewski, Jacek Niklinski, Ewa Jassem, Jacek Jassem, Joanna Jakóbkiewicz, Rafael Rosell, Maciej Żylicz, Jan Skokowski, Mariano Monzo
Publikováno v:
Lung Cancer. 34:S47-S51
Mutations of p53 suppressor gene are among the most common molecular abnormalities in human malignancies. We demonstrated earlier significant differences in mutational profiles between NSCLC patients from Poland and Spain. These differences were most
Autor:
Jacek Bigda, Jacek Jassem, Thierry Soussi, Krzysztof Konopa, Maria Poberezna, Delphine Le Roux, Tomasz Grodzki, Ewa Jassem, Beata Schlichtholz, Jan Skokowski, Rafale Dziadziuszko, Zuzanna Dobrzanska, Witold Rzyman
Publikováno v:
Lung Cancer. 31:17-23
Prognostic relevance of serum p53 antibodies was assessed in 96 patients with microscopically proven small cell lung cancer (SCLC). The study group included 67 males and 29 females; mean age 58 years; range 35‐86 years; 60 with limited disease (LD)